Skip to main content
Top
Published in: Current Neurology and Neuroscience Reports 9/2019

01-09-2019 | Hydrocephalus | Behavior (H. Kirshner, Section Editor)

Atypical Clinical Manifestations of Cerebral Amyloid Angiopathy

Authors: Carolyn Akers, Lealani May Y. Acosta, Ciaran Considine, Daniel Claassen, Howard Kirshner, Matthew Schrag

Published in: Current Neurology and Neuroscience Reports | Issue 9/2019

Login to get access

Abstract

Purpose

Cerebral amyloid angiopathy is a vasculopathy caused by β-amyloid deposition in cerebral arterioles and capillaries. It is closely linked to Alzheimer’s disease and predisposes elderly patients to intracerebral hemorrhage, transient focal neurological episodes, and cognitive impairment. Because of a predilection for symptomatic hemorrhage, particularly in the frontal lobes, cerebral amyloid angiopathy may also cause a dysexecutive syndrome.

Recent Findings

In this case series, we describe presentations of classic clinical dementia syndromes which are not are widely thought to be associated with cerebral amyloid angiopathy, namely logopenic variant primary progressive aphasia (n = 3), normal pressure hydrocephalus (n = 3), and Lewy body dementia (n = 2). In every case, after a clinical diagnosis was established, neuroimaging, brain biopsy, and/or autopsy confirmed the presence of cerebral amyloid angiopathy.

Summary

Cerebral amyloid angiopathy has significant clinical implications, and its ability to mimic and/or contribute to other clinical dementia syndromes can complicate its diagnosis. This series of cases broadens the range of clinical scenarios associated with cerebral amyloid angiopathy.
Literature
1.
go back to reference Vinters HV. Cerebral amyloid angiopathy. A critical review. Stroke. 1987;18:311–24.CrossRef Vinters HV. Cerebral amyloid angiopathy. A critical review. Stroke. 1987;18:311–24.CrossRef
2.
go back to reference Zabel M, Schrag M, Crofton A, Tung S, Beaufond P, Van Ornam J, et al. A shift in microglial β-amyloid binding in Alzheimer’s disease is associated with cerebral amyloid angiopathy. Brain Pathol. 2013;23:390–401.CrossRef Zabel M, Schrag M, Crofton A, Tung S, Beaufond P, Van Ornam J, et al. A shift in microglial β-amyloid binding in Alzheimer’s disease is associated with cerebral amyloid angiopathy. Brain Pathol. 2013;23:390–401.CrossRef
3.
go back to reference Alonzo NC, Hyman BT, Rebeck GW, Greenberg SM. Progression of cerebral amyloid angiopathy: accumulation of amyloid-beta40 in affected vessels. J Neuropathol Exp Neurol. 1998;57:353–9.CrossRef Alonzo NC, Hyman BT, Rebeck GW, Greenberg SM. Progression of cerebral amyloid angiopathy: accumulation of amyloid-beta40 in affected vessels. J Neuropathol Exp Neurol. 1998;57:353–9.CrossRef
4.
go back to reference Passiak BS, Liu D, Kresge HA, Cambronero FE, Pechman KR, Osborn KE, et al. Perivascular spaces contribute to cognition beyond other small vessel disease markers. Neurology. 2019;92:e1309–21.CrossRef Passiak BS, Liu D, Kresge HA, Cambronero FE, Pechman KR, Osborn KE, et al. Perivascular spaces contribute to cognition beyond other small vessel disease markers. Neurology. 2019;92:e1309–21.CrossRef
5.
go back to reference Schrag M, Greer DM. Clinical associations of cerebral microbleeds on magnetic resonance neuroimaging. J Stroke Cerebrovasc Dis. 2014;23:2489–97.CrossRef Schrag M, Greer DM. Clinical associations of cerebral microbleeds on magnetic resonance neuroimaging. J Stroke Cerebrovasc Dis. 2014;23:2489–97.CrossRef
6.
go back to reference Schrag M, McAuley G, Pomakian J, Jeffry A, Tung S, Mueller C, et al. Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study. Acta Neuropathol. 2010;119:291–302.CrossRef Schrag M, McAuley G, Pomakian J, Jeffry A, Tung S, Mueller C, et al. Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study. Acta Neuropathol. 2010;119:291–302.CrossRef
7.
go back to reference McAuley G, Schrag M, Barnes S, Obenaus A, Dickson A, Holshouser B, et al. Iron quantification of microbleeds in postmortem brain. Magn Reson Med. 2011;65:1592–601.CrossRef McAuley G, Schrag M, Barnes S, Obenaus A, Dickson A, Holshouser B, et al. Iron quantification of microbleeds in postmortem brain. Magn Reson Med. 2011;65:1592–601.CrossRef
8.
go back to reference Schrag M, Kirshner H. Neuropsychological effects of cerebral amyloid angiopathy. Curr Neurol Neurosci Rep. 2016;16:76.CrossRef Schrag M, Kirshner H. Neuropsychological effects of cerebral amyloid angiopathy. Curr Neurol Neurosci Rep. 2016;16:76.CrossRef
9.
go back to reference Vinters HV, Gilbert JJ. Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke. 1983;14:924–8.CrossRef Vinters HV, Gilbert JJ. Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke. 1983;14:924–8.CrossRef
10.
go back to reference Charidimou A, Boulouis G, Gurol ME, Ayata C, Bacskai BJ, Frosch MP, et al. Emerging concepts in sporadic cerebral amyloid angiopathy. Brain. 2017;140:1829–50.CrossRef Charidimou A, Boulouis G, Gurol ME, Ayata C, Bacskai BJ, Frosch MP, et al. Emerging concepts in sporadic cerebral amyloid angiopathy. Brain. 2017;140:1829–50.CrossRef
11.
go back to reference Jellinger KA, Attems J. Prevalence and pathogenic role of cerebrovascular lesions in Alzheimer disease. J Neurol Sci. 2005;229–230:37–41.CrossRef Jellinger KA, Attems J. Prevalence and pathogenic role of cerebrovascular lesions in Alzheimer disease. J Neurol Sci. 2005;229–230:37–41.CrossRef
12.
go back to reference Nicoll JAR, Yamada M, Frackowiak J, Mazur-Kolecka B, Weller RO. Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer’s disease: pro-CAA position statement. Neurobiol Aging. 2004;25:589–97.CrossRef Nicoll JAR, Yamada M, Frackowiak J, Mazur-Kolecka B, Weller RO. Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer’s disease: pro-CAA position statement. Neurobiol Aging. 2004;25:589–97.CrossRef
13.
go back to reference Boyle PA, Yu L, Nag S, Leurgans S, Wilson RS, Bennett DA, et al. Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons. Neurology. 2015;85:1930–6.CrossRef Boyle PA, Yu L, Nag S, Leurgans S, Wilson RS, Bennett DA, et al. Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons. Neurology. 2015;85:1930–6.CrossRef
14.
go back to reference Mesker DJ, Poels MM, Ikram MA, Vernooj MW, Hofman A, Vrooman HA, et al. Lobar distribution of cerebral microbleeds: the Rotterdam Scan Study. Arch Neurol. 2011;68:656–9.CrossRef Mesker DJ, Poels MM, Ikram MA, Vernooj MW, Hofman A, Vrooman HA, et al. Lobar distribution of cerebral microbleeds: the Rotterdam Scan Study. Arch Neurol. 2011;68:656–9.CrossRef
15.
go back to reference McCarron MO, Nicoll JAR. Cerebral amyloid angiopathy and thrombolysis-related intracerebral haemorrhage. Lancet Neurol. 2004;3:484–92.CrossRef McCarron MO, Nicoll JAR. Cerebral amyloid angiopathy and thrombolysis-related intracerebral haemorrhage. Lancet Neurol. 2004;3:484–92.CrossRef
16.
go back to reference Charidimou A, Boulouis G, Roongpiboonsopit D, Auriel E, Pasi M, Haley K, et al. Cortical superficial siderosis multifocality in cerebral amyloid angiopathy. Neurology. 2017;89:2128–35.CrossRef Charidimou A, Boulouis G, Roongpiboonsopit D, Auriel E, Pasi M, Haley K, et al. Cortical superficial siderosis multifocality in cerebral amyloid angiopathy. Neurology. 2017;89:2128–35.CrossRef
17.
go back to reference Charidimou A, Jager RH, Fox Z, Peeters A, Vandermeeren Y, Laloux P, et al. Prevalence and mechanisms of cortical superficial siderosis in cerebral amyloid angiopathy. Neurology. 2013;81:626–32.CrossRef Charidimou A, Jager RH, Fox Z, Peeters A, Vandermeeren Y, Laloux P, et al. Prevalence and mechanisms of cortical superficial siderosis in cerebral amyloid angiopathy. Neurology. 2013;81:626–32.CrossRef
18.
go back to reference Malhotra A, Schindler J, Mac Grory B, Chu S, Youn TS, Matouk C, et al. Cerebral microhemorrhages and meningeal siderosis in infective endocarditis. Cerebrovasc Dis. 2017;43:59–67.CrossRef Malhotra A, Schindler J, Mac Grory B, Chu S, Youn TS, Matouk C, et al. Cerebral microhemorrhages and meningeal siderosis in infective endocarditis. Cerebrovasc Dis. 2017;43:59–67.CrossRef
19.
go back to reference Vonsattel JP, Myers RH, Hedley-Whyte ET, Ropper AH, Bird AH, Richardson EP Jr. Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol. 1991;30:637–49.CrossRef Vonsattel JP, Myers RH, Hedley-Whyte ET, Ropper AH, Bird AH, Richardson EP Jr. Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol. 1991;30:637–49.CrossRef
20.
go back to reference Kirshner HS, Bradshaw M. The inflammatory form of cerebral amyloid angiopathy or “cerebral amyloid angiopathy-related inflammation” (CAARI). Curr Neurol Neurosci Rep. 2015;15:54.CrossRef Kirshner HS, Bradshaw M. The inflammatory form of cerebral amyloid angiopathy or “cerebral amyloid angiopathy-related inflammation” (CAARI). Curr Neurol Neurosci Rep. 2015;15:54.CrossRef
21.
go back to reference Renard D, Wacongne A, Thouvenot E. Radiologically isolated cerebral amyloid angiopathy-related inflammation. J Stroke Cerebrovasc Dis. 2017;26:e218–20.CrossRef Renard D, Wacongne A, Thouvenot E. Radiologically isolated cerebral amyloid angiopathy-related inflammation. J Stroke Cerebrovasc Dis. 2017;26:e218–20.CrossRef
22.
go back to reference Carlson C, Estergard W, Oh J, Suhy J, Jack CR Jr, Siemers E, et al. Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer’s disease study cohorts from phase 3 trials of semagacestat and solanezumab. Alzheimers Dement J Alzheimers Assoc. 2011;7:396–401.CrossRef Carlson C, Estergard W, Oh J, Suhy J, Jack CR Jr, Siemers E, et al. Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer’s disease study cohorts from phase 3 trials of semagacestat and solanezumab. Alzheimers Dement J Alzheimers Assoc. 2011;7:396–401.CrossRef
23.
go back to reference Whitwell JL, Kantarci K, Weigand SD, Lundt ES, Gunter JL, Duffy JR, et al. Microbleeds in atypical presentations of Alzheimer’s disease: a comparison to dementia of the Alzheimer’s type. J Alzheimers Dis. 2015;45:1109–17.CrossRef Whitwell JL, Kantarci K, Weigand SD, Lundt ES, Gunter JL, Duffy JR, et al. Microbleeds in atypical presentations of Alzheimer’s disease: a comparison to dementia of the Alzheimer’s type. J Alzheimers Dis. 2015;45:1109–17.CrossRef
24.
go back to reference Kirsch WM, McAuley G, Holshouser B, Petersen F, Ayaz M, Vinters HV, et al. Serial susceptibility weighted MRI measures brain iron and microbleeds in dementia. J Alzheimers Dis. 2009;7:599–609.CrossRef Kirsch WM, McAuley G, Holshouser B, Petersen F, Ayaz M, Vinters HV, et al. Serial susceptibility weighted MRI measures brain iron and microbleeds in dementia. J Alzheimers Dis. 2009;7:599–609.CrossRef
25.
go back to reference Whitwell JL, Jack CR Jr, Duffy JR, Strand EA, Gunter JL, Senjem ML, et al. Microbleeds in the logopenic variant of primary progressive aphasia. Alzheimers Dement. 2014;10:62–6.CrossRef Whitwell JL, Jack CR Jr, Duffy JR, Strand EA, Gunter JL, Senjem ML, et al. Microbleeds in the logopenic variant of primary progressive aphasia. Alzheimers Dement. 2014;10:62–6.CrossRef
26.
go back to reference Whitwell JL, Lowe VJ, Duffy JR, Strand EA, Machulda MM, Kantarci K, et al. Elevated occipital β-amyloid deposition is associated with widespread cognitive impairment in logopenic progressive aphasia. J Neurol Neurosurg Psychiatry. 2013;84:1357–64.CrossRef Whitwell JL, Lowe VJ, Duffy JR, Strand EA, Machulda MM, Kantarci K, et al. Elevated occipital β-amyloid deposition is associated with widespread cognitive impairment in logopenic progressive aphasia. J Neurol Neurosurg Psychiatry. 2013;84:1357–64.CrossRef
27.
go back to reference •• Mendes A, Bertrand A, Lamari F, Colliot O, Routier A, Godefroy O, et al. Cerebral microbleeds and CSF Alzheimer biomarkers in primary progressive aphasias. Neurology. 2018;90:e1057–65. This study links the logopenic variant of primary progressive aphasia to cerebral amyloid angiopathy (indicated by the presence of lobar cerebral microhemorrhages) in a high percentage of cases. CrossRef •• Mendes A, Bertrand A, Lamari F, Colliot O, Routier A, Godefroy O, et al. Cerebral microbleeds and CSF Alzheimer biomarkers in primary progressive aphasias. Neurology. 2018;90:e1057–65. This study links the logopenic variant of primary progressive aphasia to cerebral amyloid angiopathy (indicated by the presence of lobar cerebral microhemorrhages) in a high percentage of cases. CrossRef
28.
go back to reference De Reuck J. The impact of cerebral amyloid angiopathy in various neurodegenerative dementia syndromes: a neuropathological study. Neurol Res Int. 2019;7247325. De Reuck J. The impact of cerebral amyloid angiopathy in various neurodegenerative dementia syndromes: a neuropathological study. Neurol Res Int. 2019;7247325.
29.
go back to reference Jellinger KA, Attems J. Cerebral amyloid angiopathy in Lewy body disease. J Neural Transm. 2008;115:473–82.CrossRef Jellinger KA, Attems J. Cerebral amyloid angiopathy in Lewy body disease. J Neural Transm. 2008;115:473–82.CrossRef
30.
go back to reference •• Vik-Mo AO, Bencze J, Ballard C, Hortobágyi T, Aarsland D. Advanced cerebral amyloid angiopathy and small vessel disease are associated with psychosis in Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 2018:318445. https://doi.org/10.1136/jnnp-2018-318445. This is the first report of a strong connection between severe cerebral amyloid angiopathy and psychosis, an issue we have confronted frequently in clinical practice. CrossRef •• Vik-Mo AO, Bencze J, Ballard C, Hortobágyi T, Aarsland D. Advanced cerebral amyloid angiopathy and small vessel disease are associated with psychosis in Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 2018:318445. https://​doi.​org/​10.​1136/​jnnp-2018-318445. This is the first report of a strong connection between severe cerebral amyloid angiopathy and psychosis, an issue we have confronted frequently in clinical practice. CrossRef
31.
go back to reference • Pomeraniec IJ, Taylor DG, Bond AE, Lopes MB. Concurrent Alzheimer’s pathology in patients with clinical normal pressure hydrocephalus. J Neurosurg Sci. 2018. https://doi.org/10.23736/S0390-5616.18.04350-3. This study demonstrated that cerebral amyloid angiopathy is present in 9% of brain biopsies from patients with normal pressure hydrocephalus. • Pomeraniec IJ, Taylor DG, Bond AE, Lopes MB. Concurrent Alzheimer’s pathology in patients with clinical normal pressure hydrocephalus. J Neurosurg Sci. 2018. https://​doi.​org/​10.​23736/​S0390-5616.​18.​04350-3. This study demonstrated that cerebral amyloid angiopathy is present in 9% of brain biopsies from patients with normal pressure hydrocephalus.
32.
go back to reference Schrag M, Crofton A, Zabel M, Jeffry A, Kirsch D, Dickson A, et al. Effect of cerebral amyloid angiopathy on brain iron, copper, and zinc in Alzheimer’s disease. J Alzheimers Dis. 2011;24:137–49.CrossRef Schrag M, Crofton A, Zabel M, Jeffry A, Kirsch D, Dickson A, et al. Effect of cerebral amyloid angiopathy on brain iron, copper, and zinc in Alzheimer’s disease. J Alzheimers Dis. 2011;24:137–49.CrossRef
Metadata
Title
Atypical Clinical Manifestations of Cerebral Amyloid Angiopathy
Authors
Carolyn Akers
Lealani May Y. Acosta
Ciaran Considine
Daniel Claassen
Howard Kirshner
Matthew Schrag
Publication date
01-09-2019
Publisher
Springer US
Published in
Current Neurology and Neuroscience Reports / Issue 9/2019
Print ISSN: 1528-4042
Electronic ISSN: 1534-6293
DOI
https://doi.org/10.1007/s11910-019-0981-4

Other articles of this Issue 9/2019

Current Neurology and Neuroscience Reports 9/2019 Go to the issue

Stroke (H.C. Diener, Section Editor)

Antiplatelet Therapy in Cerebral Small Vessel Disease

Stroke (H.C. Diener, Section Editor)

Multimodal CT in Acute Stroke

Neurotrauma (D. Sandsmark, Section Editor)

Semiology and Mechanisms of Near-Death Experiences

Sleep (M. Thorpy and M. Billiard, Section Editors)

The Comorbidity of Migraine and Restless Legs Syndrome